The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of stromal-targeting antitumor CAR T cells in solid tumors.
 
Abdul Khan
No Relationships to Disclose
 
Thoihen Meitei Heikrujam
No Relationships to Disclose
 
Renier Brentjens
Stock and Other Ownership Interests - JUNO Therapeutics
Consulting or Advisory Role - Atara Biotherapeutics; BMS; CARGO Therapeutics; CoImmune; Gracell Biotechnologies; JUNO Therapeutics; Triumvira Immunologics, Inc
Research Funding - JUNO Therapeutics
Patents, Royalties, Other Intellectual Property - Caribou Biosciences; Sanofi; Scientific Cofounder of JUNO therapeutics